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2000Repairing the efficiency loss due to
varying cluster sizes in two-level two-
armed randomized trials with
heterogeneous clustering
Math J. J. M. Candel*† and Gerard J. P. Van Breukelen
In two-armed trials with clustered observations the arms may differ in terms of (i) the intraclass correlation, (ii)
the outcome variance, (iii) the average cluster size, and (iv) the number of clusters. For a linear mixed model
analysis of the treatment effect, this paper examines the expected efficiency loss due to varying cluster sizes based
upon the asymptotic relative efficiency of varying versus constant cluster sizes. Simple, but nearly cost-optimal,
correction factors are derived for the numbers of clusters to repair this efficiency loss. In an extensive Monte
Carlo simulation, the accuracy of the asymptotic relative efficiency and its Taylor approximation are examined
for small sample sizes. Practical guidelines are derived to correct the numbers of clusters calculated under con-
stant cluster sizes (within each treatment) when planning a study. Because of the variety of simulation conditions,
these guidelines can be considered conservative but safe in many realistic situations. Copyright © 2016 John
Wiley & Sons, Ltd.
Keywords: asymptotic relative efficiency; cluster randomized trials; individually randomized group treatment;
therapist effects; varying cluster sizes
1. Introduction
Trials evaluating the effect of a treatment are often characterized by observations that are correlated
within clusters. A prototypical example is cluster randomized trials [1], where organizational units, such
as general practices, instead of individuals, such as patients, are assigned to one of several treatment con-
ditions, and all individuals within the same unit receive the same treatment, such as a certain medication
regime. Clustering of observations may also occur when individuals are the units of assignment, but the
treatment itself induces clustering, for instance, when treatments are delivered in group sessions as in
psychotherapy [2]. In such individually randomized group treatment trials [3–5], interactions between
persons within a group may lead to their outcomes being correlated. An example is a study by Baldwin
et al. [4], in which high school and university students expressing body image concerns either received a
group-administered dissonance intervention or a group-administered healthy weight management program.
Here, clustering was found on the score on the Revised Ideal Body Stereotype Scale, a self-report measure
of internalization of the thin beauty ideal. Clustering effects due to treatment may even occur if the treat-
ment is given on an individual basis. Patients that are treated by the same therapist or, more generally,
the same care provider, will be treated in a more similar way than patients treated by different therapists.
Such therapist effects may also be a source of observations becoming correlated within groups [2,3,6].
For two-armed designs with clusters of correlated observations in each arm, formulas for sample size
calculation have been derived [1,7,8], assuming the arms have the same outcome variance, the same
intraclass correlation, the same number of clusters and the same cluster size. However, the outcome var-
iance is likely to be heterogeneous across treatments if they have any effect on the outcome variable [9],Department of Methodology and Statistics, School for Public Health and Primary Care CAPHRI, Maastricht University,
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the total research costs when the cost per cluster respectively per person differs between treatment arms
[8,10] or simply due to the nature of the treatments, for instance in comparing two forms of group psy-
chotherapy which differ in the maximum feasible group size. Such heterogeneity of variance and sample
size between treatment arms must be taken into account in the model for data analysis and consequently
also in the sample size calculation. For a two-sample t-test, it is well known that neglecting the hetero-
geneity in outcome variance between treatment arms may lead to biased tests, especially when the group
sizes differ between treatments arms and the extent of heterogeneity is large (e.g. [11,12]). Because a
mixed model analysis of two-armed cluster randomized trials is equivalent to a two sample t-test on clus-
ter means if clusters are equally sized within arms [13], similar biases will occur in such a mixed model
analysis if the variance parameters and the number of clusters differ between treatment arms, whereas
the model for analysis assumes homogeneity of variance.
Formulas for sample size calculation that accommodate heterogeneity of variance and sample size be-
tween arms in the context of a linear mixed model analysis have been presented by Candel et al. [13].
However, these formulas assume that cluster sizes are equal within (but not between) treatment arms,
whereas varying cluster sizes is the more common case. Therefore, this paper will examine the effect
of cluster size variation within arms on design efficiency in the presence of heterogeneity of variance
and sample size between arms. It will also examine how to repair the efficiency loss incurred by cluster
size variation in a cost-efficient way when planning sample sizes.
The efficiency loss will be studied for a mixed effects approach to analyzing the data. An alternative is
the generalized estimating approach, which may be more robust to misspecifying the random effects part
of the model, provided the sample size is large [14]. However, for small numbers of clusters generalized
estimating equations is known to lead to biased estimates of the standard errors of the fixed effects
estimators, yielding inflated type I error rates and undercoverage of confidence intervals [15,16]. For
small numbers of clusters, sometimes an analysis on cluster summary measures, notably cluster means,
is advised (e.g. [17]). Unequal cluster sizes imply heteroscedasticity of cluster means, however, which
invalidates the unpaired t-test on cluster means. In this paper, we will therefore consider a mixed effects
approach.
The efficiency loss due to varying cluster sizes within arms will be derived for the asymptotic case
and checked for finite samples in an extensive Monte Carlo simulation study, considering both
maximum likelihood (ML) and restricted maximum likelihood estimation (REML). A simple Taylor
approximation of the asymptotic efficiency loss, based on the coefficient of variation of cluster sizes,
will be derived and checked against the simulation results. This approximation may be very practical
in taking care of the efficiency loss when planning a study. For the case of homogeneity of intraclass
correlation, outcome variance, number of clusters, average cluster size and cluster size distribution
between arms, this Taylor approximation is known to be much more precise than a commonly used
approximation based on cluster size weighting [18–20]. We will also briefly examine to what extent
this is true when there is between-arm heterogeneity in the variance parameters as well as in the num-
ber of clusters and the average cluster sizes. Furthermore, because of the small sample characteristics
of individually randomized group treatment trials and trials with therapist effects, the accuracy of the
asymptotic approximation and the Taylor approximation is studied for cluster sizes smaller than
considered before [21,22].
The paper is structured as follows. Section 2 presents the linear mixed effects model for two-armed
trials, allowing for different intraclass correlations, different outcome variances, different cluster numbers
and different cluster sizes in these arms. Section 3 then presents the asymptotic relative efficiency (ARE) of
unequal versus equal cluster sizes within arms, and Section 4 presents a Taylor approximation to this ARE that
can be used to compensate for the expected efficiency loss because of cluster size variation in planning a study.
Section 5 discusses a Monte Carlo study evaluating the accuracy of the ARE and its Taylor approximation for
various cluster size distributions with realistic sample sizes. Section 6 illustrates how to apply the results in
planning the sample sizes for a trial, whereas Section 7 summarizes the implications of the present study.20012. Specification of the linear mixed effects model
In the treatment and control condition, we have respectively Kt and Kc clusters (such as Kt and Kc
therapy groups). In cluster j (j=1, …, Kt) of the treatment condition, there are m
t
j persons, and in cluster
j (j=Kt+1, …, Kt+Kc) of the control condition, there are m
c
j persons, the total number of persons thusCopyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015







mcj . The dependent variable is a quantitative outcome, denoted as yij for
person i in cluster j ( j=1,…, Kt+Kc). If in each condition yij is (approximately) normally distributed, the fol-
lowing linear mixed effects model is an adequate tool for data analysis (cf. Roberts et al. [2];Walwyn et al. [6]):
yij ¼ β0 þ β1 þ uj þ δij
 





where Intij denotes the treatment condition for person i in cluster j, which is coded as 1 for persons in the treat-
ment condition and coded 0 for persons in the control condition. With this coding scheme, β0 represents the
mean score of the control condition, and β1 represents the treatment effect, such as the mean outcome differ-
ence between cognitive behavioural therapy and psychodynamic interpersonal psychotherapy [5]. Commonly,
β1 is the parameter of primary interest. The terms uj and vj represent the random cluster effect in the treatment
and control condition, respectively, whereas δij and εij represent a random person effect in these conditions, re-





ε . The total outcome variances for the treatment and control arm are σ
2
yt
¼ σ2u þ σ2δ and
σ2yc ¼ σ2v þ σ2ε .
The intraclass correlation measures the dependency among observations for members within the same
cluster. For the model in Eqn (1) the intraclass correlations are ρt ¼ σ2u= σ2u þ σ2δ
  ¼ σ2u=σ2yt for the treat-
ment arm and ρc ¼ σ2v= σ2v þ σ2ε
  ¼ σ2v=σ2yc for the control arm. The correlation between two randomly
drawn persons from two different clusters is zero.
3. Asymptotic relative efficiency
Let ξequal and ξunequal denote two designs with the same numbers of clusters Kt, Kc and the same average
cluster sizes m t, m c for the two treatment arms, but differing in that the cluster sizes within each treat-





corresponding asymptotic variances of the treatment effect estimator. The asymptotic relative efficiency
(ARE) of a design with unequal versus a design with equal cluster sizes for the estimator of the treatment
effect, RE β̂1
 










Commonly, β̂1 is the ML estimator, and for this case, an expression for the ARE in Eqn (2) can be
derived. Let m t and m c denote the average cluster size of the Kt and Kc clusters in the treatment and
control arm, respectively. Let wtj and w
c
j be defined as w
t
j ¼ σ2u þ σ2δ=mtj
 1
and wcj ¼ σ2v þ σ2ε=mcj
 1
.
For equal cluster sizes in the treated arm, we have mtj ¼ m t for j=1, …, Kt, and the weight wtj




Kt+1, …, Kt+Kc, and the weight w
c
j is denoted as w
c
e . In Appendix A, it is shown that the ARE for



















































































and 1, respectively. We define ψ = σ2yt=σ
2
yc
, which is the treatment-to-control ratio of total outcomeCopyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015












if the variance ratio ψ, or the allocation ratio Kc /Kt, or the average cluster size
m c in the control arm, or the intraclass correlation ρt in the treated arm, increases. On the other hand, if
ψ, or Kc /Kt decreases, or if the average cluster sizem
t in the treated arm or the intraclass correlation ρc






















are the relative efficiencies in cluster randomized trials for esti-
mators of the treatment and control mean, respectively [19]. So the relative efficiency of β̂1 actually




¼ Kc=Ktð Þ σ2u þ σ2δ=m t
 
= σ2v þ σ2ε=mc
  
, the weight of an arm increases with its outcome
variance at either cluster or subject level, and decreases with its sample size at either level, keeping
variances and sample sizes in the other arm constant. Van Breukelen et al. [19] have shown that the
ARE of varying versus equal cluster sizes within an arm does not depend on the absolute number of
clusters (here: Kt resp. Kc) and does not exceed 1, but approaches 1 as the intraclass correlation





does not depend on the cluster numbers in each of the treatment arms, as long as the ratio
Kt /Kc remains the same.
(2) If ρt → 0 and ρc → 0 or ρt → 1 and ρc → 1, then RE β̂1
 
→ 1.
(3) For 0<ρt <1 or 0<ρc<1, it holds that RE β̂1
 
≤1: equal cluster sizes are most efficient.
4. Taylor approximation of the asymptotic relative efficiency
To plan sample sizes, it will be useful to have an approximation of the efficiency loss that does not need
an exact specification of the cluster size distribution. For such practical purposes, we will present a
second-order Taylor approximation of the ARE in Eqn (3), which only depends on the mean and vari-
ance of the cluster size distribution. The approximation is based on a stochastic cluster size distribution.
Eqn (3) expresses the relative efficiency for a particular realization from such a stochastic cluster size
distribution. Second-order Taylor approximations have been derived for the ARE when estimating the
mean in the treatment or control arm of a cluster randomized trial [19]. Because the ARE for the treat-
ment effect in a cluster randomized trial with treatment arms that are heterogeneous in terms of the
intraclass correlation, outcome variance, average cluster size and cluster numbers is the weighted har-
monic mean of the relative efficiencies for the two arm-specific outcome means, a Taylor approximation
for Eqn (3) immediately follows from Van Breukelen et al. [19].
Consider mtj for j=1, …, Kt and m
c
j for j=Kt+1, …, Kt+Kc in Eqn (3) as independent realizations of
random variables with expectations μtm and μ
c













m be the coefficients of variation of cluster sizes for the treatment and con-
trol arm, respectively. Furthermore, let λt ¼ μtm= μtm þ 1 ρtð Þ=ρt
 
, and let λc ¼
μcm= μ
c
m þ 1 ρcð Þ=ρc
 
. The second-order Taylor approximation of the ARE in Eqn (3) can then be derived
as the weighted harmonic mean of 1 CV2t λt 1 λtð Þ and 1 CV2cλc 1 λcð Þ, the second-order Taylor
approximations of the ARE for the treatment and control mean [19], with weights ψ(Kc/Kt)(λc/λt)(ρt /ρc)
and 1, respectively:
RET ¼ Kcλcρtψ þ Ktλtρcð Þ
Kcλcρtψ
1 CV2t λt 1 λtð Þ
 !
þ Ktλtρc
1 CV2cλc 1 λcð Þ
 !" #1
: (4)
The Taylor approximation in Eqn (4) generalizes the expression derived by Van Breukelen
et al. (p. 2594) [19] for the case of trials with homogeneous clustering. As the variance at theCopyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
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2004cluster or subject level in the treatment arm, σ2u and σ
2
δ, increases, or its sample size at either level,
Kt or μ
t
m, decreases, Eqn (4) approaches 1 CV2t λt 1 λtð Þ. Likewise, as the variance at the cluster
or subject level in the control arm, σ2v and σ
2
ε, increases or its sample size at either level, Kc or μ
c
m,
decreases, Eqn (4) approaches 1 CV2cλc 1 λcð Þ. Furthermore, when ρt→ 0 and ρc→ 0 (and thus
λt→0 and λc→0) or ρt→1 and ρc→1 (and thus λt→1 and λc→ 1), RET→1, and for 0< ρt,
ρc<1, RET≤1. As CVt and CVc increase, RET will decrease, and if λt= λc=1/2, then 1 CV2t λt 1 λtð Þ
and 1 CV2cλc 1 λcð Þ each reach their minimum. Therefore, denoting by CVmax the maximum of CVt
and CVc, the minimum value of Eqn (4) is (1CV2max/4).
The approximation of the RE as derived in Eqn (4) can be compared with an approximation based on
an analysis involving cluster size weighting (cf. [18,23]). In this case, the relative efficiency also is a
weighted harmonic mean of the relative efficiencies in each of the treatment conditions, with the same
weight per arm as aforementioned for Eqn (4). Because the RE for the mean of the treatment and control
condition can then be approximated by 1= 1þ CV2t λt
 
and 1= 1þ CV2cλc
 
, respectively (cf. [23]), the
following approximation is obtained based on cluster size weighting:
REcsw ¼ Kcλcρtψ þ Ktλtρcð Þ Kcλcρtψ 1þ CV2t λt
 þ Ktλtρc 1þ CV2cλc  1: (5)
For homogeneous cluster randomized trials, it has been shown that the approximation based on cluster size
weighting gives a rather pessimistic estimate of the efficiency loss in case of (restricted)ML estimation in amixed
effects model, and is less close to the true efficiency loss than the second-order Taylor approximation ([20]). This
will also be the case for the efficiency loss as predicted by Eqn (5), which is based on cluster size weighting.
5. Monte Carlo investigation of the relative efficiency
We will examine the accuracy of the ARE in Eqn (3) and its Taylor approximation in Eqn (4) through a
Monte Carlo simulation study. More specifically, we will calculate the ratio of the simulated variance of
the treatment estimator for equal cluster sizes to the simulated variance of the treatment estimator for un-
equal cluster sizes, and compare that ratio with Eqns (3) and (4). We will allow the intraclass correla-
tions, the variances within treatment conditions, the mean cluster sizes and the number of clusters to
differ between the treatment arms. Randomization may be assumed to imply similar shapes of the cluster
size distributions in the two treatment arms, but the coefficient of variation may be different because the
planned average cluster size may differ between arms, that is, m t ≠m c.
5.1. Design of the simulation study
In the simulation study, the intercept β0 and the effect parameter β1 in Eqn (1) were fixed at 50 and 5,
respectively. This could be done without loss of generality, because the asymptotic variance of the
effect estimator is independent of the fixed regression weights (see Eqn (A2) in appendix A). The
following factors were varied systematically in the simulation study, as they enter into Eqns (3) and
(4): (i) the frequency distribution of the cluster sizes; (ii) the size of the intraclass correlations ρt and
ρc; (iii) the variance ratio ψ; (iv) the ratio of cluster numbers Kt /Kc and (v) the average cluster sizesTable I. Overview of the conditions of the Monte Carlo simulation
Factor Levels
Cluster size distribution1 Unimodal, uniform, bimodal, positively skewed,
negatively skewed distribution
Intraclass correlations ρt, ρc= 0.01 up to 0.29
Ratio of variances (treatment vs control arm) ψ = 0.25, 1, 4
Average cluster size2 (m t , m c) = (4, 4), (10, 4) or (10,10)
Ratio of cluster numbers (treatment vs control arm) Kt /Kc = 0.25 (6/24), Kt /Kc = 1 (12/12) Kt /Kc= 4 (24/6)
Estimation method ML, REML
1More details on the different cluster size distributions are given in Table 2a and b.
2A larger average cluster size of 10 enables examining the effect of a larger range of cluster sizes and of average clus-
ter sizes differing between the treatment arms.
ML, maximum likelihood; REML, restricted maximum likelihood.
Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
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factors, the motivation will be given below.5.1.1. Distribution of cluster sizes
Five different cluster size distributions were studied: (i) a unimodal; (ii) a uniform; (iii) a bimodal; (iv) a
positively skewed and (v) a negatively skewed distribution. Details of the cluster size distributions can
be found in Table 2a and b.Table II. Cluster size distributions 1 in treatment arm with average cluster size = 4 (a) 2 and with average
cluster size = 10 (b) 3
Distribution Cluster sizes Cluster frequencies Coefficient of variation
(CV) of cluster sizes4ga gb gc fa fb fc
(a)
Unimodal
Kt = 24 2 4 6 6 12 6 0.36
Kt = 12 2 4 6 2 8 2 0.30
Kt = 6 2 4 6 1 4 1 0.32
Uniform
Kt = 24 2 4 6 8 8 8 0.42
Kt =12 2 4 6 4 4 4 0.43
Kt = 6 2 4 6 2 2 2 0.45
Bimodal
Kt = 24 2 4 6 11 2 11 0.49
Kt = 12 2 4 6 5 2 5 0.48
Kt = 6 2 4 6 3 0 3 0.55
Positively skewed
Kt = 24 3 4 7 12 8 4 0.36
Kt = 12 3 4 7 6 4 2 0.37
Kt = 6 3 4 7 3 2 1 0.39
Negatively skewed
Kt = 24 1 4 5 4 8 12 0.36
Kt = 12 1 4 5 2 4 6 0.37
Kt = 6 1 4 5 1 2 3 0.39
(b)
Unimodal
Kt = 24 2 10 18 6 12 6 0.58
Kt = 12 2 10 18 2 8 2 0.48
Kt = 6 2 10 18 1 4 1 0.51
Uniform
Kt = 24 2 10 18 8 8 8 0.67
Kt = 12 2 10 18 4 4 4 0.68
Kt = 6 2 10 18 2 2 2 0.72
Bimodal
Kt = 24 2 10 18 11 2 11 0.78
Kt = 12 2 10 18 5 2 5 0.76
Kt = 6 2 10 18 3 0 3 0.88
Positively skewed
Kt = 24 6 10 22 12 8 4 0.58
Kt = 12 6 10 22 6 4 2 0.59
Kt = 6 6 10 22 3 2 1 0.62
Negatively skewed
Kt = 24 1 10 17 7 8 9 0.66
Kt = 12 1 8 17 3 4 5 0.68
Kt = 6 1 4 17 1 2 3 0.78
1fa, number of clusters of size ga (small); fb, number of clusters of size gb (medium); fc, number of clusters of size gc (large).
2The range of the cluster sizes = gc – ga= 4.
3The range of the cluster sizes = gc – ga= 16.
4Coefficient of variation is the standard deviation of cluster sizes divided by the mean cluster size.
Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
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20065.1.2. Intraclass correlations
The intraclass correlations ρt and ρc range from 0.01 to 0.30, because this represents the range commonly
encountered in trials comparing group administered interventions [2,4,5], trials where clustering effects
are due to therapists [2,24] and in cluster randomized trials [25,26].
5.1.3. Ratio of outcome variances
Because there is not much empirical evidence on ψ, with studies indicating that it varies between 0.5 and
2 [4], we will examine a somewhat broader range: ψ runs from 0.25 to 4.
5.1.4. Ratio of the number of clusters
TheRE β̂ 1
 
does not depend on the total number of clusters but does depend on the ratio Kt /Kc. In most
studies on group therapy (e.g. [4,27–29]), but also in cluster randomized trials (e.g. [26,30]), the cluster
numbers are very similar for both treatment arms. Because it has been shown that unequal cluster num-
bers may be optimal under heterogeneity of outcome variance [13], in our simulations, next to Kt /Kc=1,
we will also consider Kt /Kc=0.25 and Kt /Kc=4. Kt and Kc were deliberately chosen to be small in order
to check the accuracy of the asymptotic expression in Eqn (3), but also large enough to provide sufficient
power in a reasonable number of cases. Three sets of values were considered: (i) Kt=Kc=12; (ii) Kt=24
and Kc=6 and (iii) Kt=6 and Kc=24.
5.1.5. Average cluster sizes
An average cluster size of four was chosen, with a range of four, because this is about the smallest
average cluster size encountered (especially in group therapy see, for instance, [5,29,31]). An aver-
age cluster size of 10 was also examined, because this allows for a larger range of cluster sizes.
More specifically, a rather extreme range of 16 was chosen, which, for symmetrical distributions,
implies that the smallest m=2 and the largest m=18. The cluster sizes were deliberately chosen
small in order to check the accuracy of the asymptotic expression in Eqn (3). Simulations were per-
formed with (i) an average cluster size m t =m c =4 for both the treatment and control arm, (ii) an
average cluster size m t =10 for the treatment and an average cluster size m c =4 for the control arm,
and (iii) an average cluster size m t =m c =10 for both arms. In many studies (e.g. [4,29,30]), the ratio of
average cluster sizesm t=m c is close to 1, but we also consider the case withm t=m c=10/4=2.5. Note that
Eqn (3) shows that the ARE does not depend on the treatment effect itself, so that the ratiom t=m c=4/10=0.4
is redundant when all combinations of levels of all other design factors have been made. This is the case,
except for the coefficient of cluster size variation which is large for large cluster sizes and small for small
cluster sizes; see Table 2a and b. To check the validity of our conclusions, we therefore also performed
35 additional simulations with coefficients of cluster size variation for small cluster sizes that are com-
parable with the coefficients of cluster size variation for large cluster sizes, and vice versa.
5.2. Simulation procedure and estimation methods
For each of the simulation conditions 10 000 data sets were generated, each representing the data for 24
or 30 clusters consisting, on the average, of 4 or 10 persons. The simulations as well as model estimation
were performed in MLWIN, version 2.0 [32]. For the analysis model as specified in Eqn (1), ML and
REML estimates were obtained through the ‘Iterative Generalized Least Squares’ and ‘Restricted
Iterative Generalized Least Squares’ algorithm, respectively, with negative estimates of the variance
components being truncated to 0. Nontruncation of negative variance estimates in many cases led to
nonconvergence, and therefore was not considered further. The convergence criterion was set to
0.001, that is, the estimation algorithm stopped when the relative change for all parameter estimates
was less than 0.001. To speed up the simulations, the number of iterations was maximized at 200,
resulting in less than 1% nonconverged runs, and for the majority of simulation scenarios even less than
0.5% nonconverged runs. Based on the treatment effect estimates, the sampling variance of β̂1 was cal-
culated for equal and for varying cluster sizes, allowing the RE in Eqn(2) to be calculated as the golden
standard against which the approximations in Eqns (3), (4) and (5) could be compared. Detailed codes
for the programs MLWIN, SPSS and R to run the analysis model in Eqn (1) are provided as supporting




Figure 1. Relative efficiency of the treatment effect estimator for a positively skewed (a), bimodal (b) and
unimodal distribution of cluster sizes (c) as a function of the intraclass correlation in the treatment condition,
ρt, with ψ = 4, ρc=0.15, Kt /Kc=¼. The top curves in (a) and (b) are for mt = mc = 4, all other curves are for
mt = mc = 10. The asymptotic relative efficiency of the ML estimator and its Taylor approximation are also
displayed. CV: coefficient of cluster size variation.
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20075.3. Results for homogeneous average cluster sizes
For ψ =4, Kt /Kc=1/4 and ρc=0.15 Figure 1 illustrates the results of distributions that give extreme re-
sults in terms of the RE: the unimodal and positively skewed distribution on the one hand and the
bimodal distribution on the other hand. The top curves in Figure 1a and b are for m t =m c = 4, the
bottom curves are for m t =m c =10. In Figure 1c, all curves are for m t =m c =10. Although changing
the between-arm ratio of outcome variances ψ or the between-arm ratio of cluster numbers Kt /Kc yields
similar results, the present values are chosen for later comparison with results for heterogeneous average
cluster sizes (Section 5.4). Further, we chose ρc=0.15 as some intermediate value of the interval [0.01, 0.30].
The effects of changing ρc are comparable with the effects of changing ρt as visible in Figure 1.Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
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2008In line with the ARE, Figure 1 shows that the simulated RE approaches 1 when ρt→ 0 and never
exceeds 1, implying that varying cluster sizes are less efficient than constant cluster sizes. Also, the
simulated RE hardly differs between REML and ML. As illustrated by the top curves in Figure 1a,
for m t = m c =4, the asymptotic and simulated RE are rather close in that the simulated RE is
overestimated by less than 2%. The exceptions are the negatively skewed distribution and bimodal
distribution where the overestimation can become 3% and 4%, respectively. This is illustrated by the
upper curves in Figure 1b. Similar conclusions can be drawn for the accuracy of the second-order Taylor
approximation in Eqn (4).
As illustrated by the lower curves of Figure 1a–c, for m t =m c =10, the ARE is less close to the sim-
ulated RE than for m t =m c =4, overestimating the RE up to 9%. This also holds for the second-order
Taylor approximation (Eqn (4)), overestimating the simulated RE in many cases by 4% (but up to
10%). The larger approximation errors of the ARE and its Taylor approximation form t =m c=10, when
compared withm t=m c=4, can be attributed to the larger coefficients of cluster size variation. Figure 1c
illustrates this for a unimodal distribution and m t =m c =10, where the upper curves are for small coef-
ficients of cluster size variation and the lower curves are for large coefficients of cluster size variation.
For the larger coefficients of cluster size variation, the approximation errors are larger.5.4. Results for heterogeneous average cluster sizes
For the case m t =10 and m c=4, ψ =4, Kt /Kc=1/4 and ρc=0.15, Figure 2 shows results for a positively
skewed, bimodal and unimodal distribution. To examine the largest efficiency loss, results are shown for
designs where the arm with the largest CV (i.e. m =10) also has the largest outcome variance and the
smallest number of clusters, such that this arm gets the largest weight in the relative efficiency according
to Eqn (3). Similar to what was observed in Figure 1, the differences in RE between ML and REML
were small for the present scenario and Figure 2 therefore only shows the REML results. In line with
the ARE, the simulated RE in Figure 2 does not exceed 1 (but approaches 1 when ρt→ 0). It can also
be seen that the minimum REs in Figure 2a and b are clearly lower than the minimum REs for the solid
lines in Figure 1a and b, but higher than the minimum REs for the dashed lines in Figure 1a and b. This
is in line with Eqn (3), which defines the ARE as the weighted harmonic mean of the relative efficiencies
of each treatment arm, with one arm in Figure 2a and b having a CV identical to the CV of the solid lines
and the other arm having a CV identical to the CV of the dashed lines in Figure 1a and b, respectively.
Figure 2 also illustrates that, compared with designs with m t =m c =4, the asymptotic and the simu-
lated RE are less close. The difference between the asymptotic and the simulated RE is less than 4%,
except for a negatively skewed and bimodal distribution where the RE may be overestimated up to
5% and 9%, respectively. The approximation errors of the second-order Taylor approximation
(Eqn (4)) can become rather large (up to 10%).
Finally, Figure 2 illustrates the improvements of the Taylor approximation derived in this study (Eqn (4)),
as compared with the approximation based on cluster size weighting (Eqn (5)). Particularly for larger intraclass
correlations, the approximation in Eqn (5) overestimates the efficiency loss to a large extent (cf. [20]).
Table 3 summarizes the minimum values for the simulated RE as well as the maximum overestima-
tions of the simulated RE by the ARE and its Taylor approximation. The minima and maxima are exam-
ined across all intraclass correlations ρt and ρc, ratios Kt /Kc and ψ. The results on overestimation can be
used in sample size planning to correct the ARE or its Taylor approximation. If there is not enough in-
formation to calculate the ARE or its Taylor approximation, the minimum of the Taylor approximation
can be used, that is, (1CV2max/4), only requiring the maximum of CVt and CVc. Table 3 therefore also
displays how much (1CV2max/4) maximally overestimates the minimum of the simulated RE.
As illustrated by Table 3, the minimum of the simulated RE depends on the type of cluster size dis-
tribution and the coefficients of cluster size variation of the treatments arms. The larger the coefficient of
cluster size variation, the smaller the minimum simulated RE. More detailed analyses (not shown) fur-
thermore show, when keeping the coefficient of cluster size variation, Kt /Kc, ψ, andm t andm c constant,
that the minimum is smallest for a negatively skewed distribution and largest for a positively skewed
distribution, with the symmetrical distributions being in between. There are no substantial effects of
Kt /Kc, ψ, and m t and m c on the minimum simulated RE.
Table 3 furthermore illustrates that the approximation errors increase with increasing coefficients of cluster
size variation of the treatment arms. From more detailed analyses (not shown) it appears that, when keeping




Figure 2. Relative efficiency of the treatment effect estimator for a positively skewed (a), bimodal (b) and
unimodal distribution of cluster sizes (c), as a function of the intraclass correlation in the treatment condition,
ρt, with ψ =4, ρc=0.15 and Kt /Kc=¼, andm t ¼ 10 in the treatment arm andmc ¼ 4 in the control arm. The asymp-
totic relative efficiency of the maximum likelihood (ML) estimator, its Taylor approximation, and the approximation
based on cluster size weighting are also displayed. CV: coefficient of cluster size variation.
M. J. J. M. CANDEL AND G. J. P. VAN BREUKELENof the RE by the Taylor approximation and of the minimum simulated RE by (1CV2max/4) also depend on the
type of cluster size distribution. Compared with the symmetric cluster size distributions, the overestimation is
smaller for a positively skewed distribution but larger for a negatively skewed distribution. Figure 3 illustrates this
for a uniform and negatively skewed distribution of cluster sizes, bothwithCVt=CVc=0.68. The approximation
error of the Taylor approximation is clearly larger for the negatively skewed distribution.20095.5. Guidelines for estimating the efficiency loss
The results from Table 3 can be used in estimating the efficiency loss. If a researcher has no specific
idea on the type of cluster size distribution, the Taylor approximation could be used, that is, Eqn (4),Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
Table III. Minimum simulated relative efficiencies (minRE), maximum overestimation of simulated RE by
the asymptotic RE (ARE) and Taylor approximation (TRE) and maximum overestimation of minRE by
(1 CV2max /4), across all intraclass correlations ρt and ρc, ratios Kt /Kc and ψ, for different sets of average
cluster sizes (CVmax: largest coefficient of cluster size variation for the two treatment arms).































Bimodal 0.91 0.04 0.02 0.76 0.09 0.05 0.75 0.09 0.06
(0.51, 0.51) 0.04 (0.81, 0.51) 0.10 (0.81, 0.81) 0.10
Uniform 0.94 0.02 0.01 0.83 0.05 0.04 0.82 0.05 0.04
(0.43, 0.43) 0.02 (0.69, 0.43) 0.07 (0.69, 0.69) 0.07
Unimodal 0.96 0.02 0.01 0.92 0.03 0.02 0.90 0.03 0.02
(0.33, 0.33) 0.02 (0.52, 0.33) 0.04 (0.52, 0.52) 0.04
Positive 0.96 0.02 0.00 0.89 0.04 0.02 0.89 0.04 0.02
skew (0.37, 0.37) 0.02 (0.60, 0.37) 0.04 (0.60, 0.60) 0.04
Negative 0.94 0.03 0.03 0.81 0.05 0.04 0.81 0.05 0.05
skew (0.37, 0.37) 0.03 (0.71, 0.37) 0.09 (0.71, 0.71) 0.09
1Within brackets the average coefficients of cluster size variation for the treatment and control arm are given.
CV: coefficient of cluster size variation.
Figure 3. Relative efficiency of the treatment effect estimator for a uniform and negatively skewed distri-
bution of cluster sizes as a function of the intraclass correlation in the treatment condition, ρt, with ψ = 4,
ρc= 0.15, Kt /Kc= 1 and m t =mc ¼ 10. The asymptotic relative efficiency of the maximum likelihood (ML)
estimator and its Taylor approximation are also displayed. CV: coefficient of cluster size variation.
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2010and, if the researcher does not have an idea of relevant model parameters (ρt, ρc and ψ), its lower-bound,
(1CV2max/4) could be used. A pessimistic scenario could then be chosen, by assuming large coefficients of
cluster size variation for each of the treatment arms. Next, the resulting RE has to be corrected for possible
overestimation according to the results in Table 3. A negatively skewed distribution should be chosen, as
this choice leads to a safe correction for overestimating the RE.
If the researcher does have a specific idea of the cluster size distribution as well as of relevant
model parameters, then the ARE in Eqn (3) can be calculated. Choosing in Table 3, a large coef-
ficient of cluster size variation for the cluster size distribution considered plausible would then again
lead to a safe correction for overestimating the RE. Of course, if a researcher has a detailed idea of
both model parameters and the cluster size distribution, also a (rather time intensive) simulation
could be performed to estimate the efficiency loss, similar to what was performed in the Monte
Carlo simulations. The code for performing such an analysis in MLWIN [32] is, upon request, avail-
able from the first author.Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
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20116. Application in planning a trial
We illustrate how the results of the present study can be used in planning a trial in which there is heteroge-
neous clustering in the treatment arms. Appendix B shows that there is only one practical way of restoring
the efficiency loss due to varying cluster sizes when estimating the treatment effect. If RE is the trial’s
relative efficiency of varying versus constant cluster sizes, the efficiency loss can be regained by multiply-
ing the number of clusters in both the treatment and control arm by 1/RE. In optimal designs, the aim is to
minimize the costs of a study for a given level of precision and power. When aiming for such a design, it
furthermore is shown in Appendix B that multiplying the number of clusters in both the treatment and con-
trol arm by 1/RE does not exactly minimize the costs of a study but is very close to minimizing these costs,
in that, in most cases, the smallest possible budget is exceeded by less than 1%.
We apply these results to a randomized trial by Baldwin et al. [4]. High school and university students
expressing body image concerns either received a group-administered dissonance intervention or a group-
administered healthy weight management program. A central outcome was the score on the Revised Ideal
Body Stereotype Scale, a self-report measure of internalization of the thin beauty ideal. The parameter es-
timates from Baldwin et al. [4] (i.e. ρ̂t =0.04, ρ̂c =0.25 and ψ̂ =0.78) could be used to specify plausible
ranges for these parameters: ρt∈ [0.01, 0.10], ρc ∈ [0.20, 0.30] and ψ ∈ [0.4, 2.5]. Based on these ranges,
a maximin design can be calculated, that is, a design which guarantees a power level within the specified
parameter ranges at the lowest costs or with the lowest number of subjects [13]. Assuming Baldwin et al.’s
[4] average cluster sizes (m t =m c=6) and aiming for 80% power to detect a medium sized effect, that is,
β1=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
0:5 σ2yt þ σ2yc
 r
=0.5 (cf. Cohen [33]), in a two-tailed test with a 5% type I error rate, one can calcu-
late, by employing a small menu-driven program CLUSCALCRT in R [13], that Kt=18 groups for the treat-
ment arm and Kc=29 groups for the control arm minimize the total sample size.
The present’s study simulations show that varying cluster sizes leads to efficiency loss. The cluster
size distribution being unknown, one may start from a pessimistic scenario, assuming rather large values
for CVt=CVc=0.70. A lower-bound for the RE according to the second-order Taylor approximation
would be 1CV2max/4= 0.88. Because this RE may underestimate the efficiency loss, a conservative,
but safe correction would be lowering the RE by the maximum approximation error found in the present
study, occurring for a negatively skewed distribution. For an average CV of 0.71 in both arms, this safe
correction is 5% (see columnm t=m c=10 in Table 3), resulting in RE=0.88–0.05=0.83. This efficiency
loss can then be restored in a (nearly) cost-optimal way by multiplying the number of groups in both
arms with 1/RE=1/0.83=1.14, yielding Kt=21 and Kc=34 groups, respectively.
Another approach to repairing the efficiency loss is to employ a simple numerical search, to find the
lowest value of the Taylor approximation in Eqn (4) for the specified plausible ranges of the parameters
also used in deriving the maximin design, that is, ρt∈ [0.01, 0.10], ρc ∈ [0.20, 0.30], and ψ ∈ [0.4, 2.5].
The lowest value turns out to be RE=0.88. The simulations show that the RE is most overestimated for a
negatively skewed distribution. In case the average CV in both arms is 0.71, the maximum overestimation,
across all intraclass correlations, variance and cluster number ratios, is 9% (see column m t =m c =10 in
Table 3). However, because 0.88 is also the minimum according to 1CV2max/4, one can infer that we only
have to correct this RE with 5%, resulting in the pessimistic estimate RE=0.88–0.05=0.83, yielding a cor-
rection factor that is identical to the first approach. Both methods thus lead to restoring the efficiency loss by
multiplying the number of groups in both arms with 1/RE=1/0.83=1.14, yielding Kt=21 and Kc=34
groups, respectively.
7. Conclusions and discussion
Clustering may occur in cluster randomized trials, where organizational units (e.g. general practices) are
assigned to treatments, in trials comparing group administered treatments (e.g. groupwise therapy), or in
trials comparing individually administered treatments where each care provider (e.g. a therapist) is
assigned a group of persons following one of the treatments. The cluster sizes and numbers of clusters
may differ across arms, and analyzing data for such designs by a linear mixed model may require allow-
ance for between-arm differences in the intraclass correlations and outcome variances. For this general
case, an expression of the ARE of varying versus constant cluster sizes was derived. Starting from this
expression, it was shown that the efficiency loss due to varying cluster sizes can be restored almost cost-
efficiently by increasing the numbers of clusters in both arms by (1/RE)1.Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015
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2012To study the accuracy of the ARE when calculating the efficiency loss for realistic sample sizes, an exten-
sive Monte Carlo simulation was performed. For coefficients of cluster size variation (CV) up to 0.60 in both
arms, the ARE was rather close to the simulated RE: lowering the ARE by 4% would then be a safe correc-
tion. For aCV up to 0.80 in one of the arms, the overestimation of the ARE could become larger, up to 9% (see
Table 3 for details). For all designs studied, the simulated RE did not differ much between ML and REML.
To facilitate taking care of the efficiency loss in planning a trial, a second-order Taylor approximation of
the AREwas derived. This approximation rather adequately described the simulated RE, the overestimation
being less than 4% if the CV in both arms did not exceed 0.50, or, for a positively skewed distribution if the
CV in both arms did not exceed 0.60. The Taylor approximation was clearly less accurate with larger CVs.
If there is no information on the intraclass correlations or the variance ratio, the second-order Taylor
approximation provides a simple formula for the minimum RE, (1CV2max/4), where CVmax is the largest
CV of the two arms. This expression can underestimate the efficiency loss, but lowering (1CV2max/4) by
1% up to 6%, depending on the CV and type of cluster size distribution (see Table 3 for details), would be
sufficient to correct for the efficiency loss in sample size calculation.
For some care providers, such as nurse practitioners or general practitioners, Kt /Kc may clearly
deviate from 1 [34,35], even close to 4 [2]. The range of ratios presently considered also encompasses
these between-arm ratios of cluster numbers. However, for these care providers, the intervention often
involves a single or a few meetings, of limited duration, implying that the average number of patients
per care provider may be much larger than considered in the present simulation study (e.g. Roberts
et al. [2]; Roth et al. [35]). Larger cluster sizes are also characteristic for community based trials in
which, for instance, villages or neighbourhoods are assigned to different treatments [17]. Designs with
large cluster sizes may show larger CVs and larger between-arm heterogeneity in terms of the average
cluster sizes. Additional simulations with larger average cluster sizes (between 10 and 120), indicate
that, provided the CV does not exceed the values in Table 2a and b, the results are similar to Table 3,
also for more extreme cluster size ratios of m t=mc =5 and m t=mc =10.
The correction factors for the number of clusters for varying cluster size derived by Candel et al. [21]
and Van Breukelen et al. [36] for trials with homogeneous clustering varied between 12% and 25%,
where homogeneous clustering means that outcome variances, intraclass correlations, number of clusters
and cluster sizes are the same across treatment arms. The simulated relative efficiencies of the present
study show that the correction factors for the number of clusters in case of heterogeneous clustering
may become somewhat larger, partially because larger coefficients of cluster size variation were consid-
ered. A more systematic investigation would be required to explore to what extent smaller cluster sizes
and smaller numbers of clusters are responsible for these larger correction factors in the case of hetero-
geneous clustering. Pending such an investigation, the corrections reported in the current study can be
considered conservative corrections that are also safe for larger sample sizes.
The Monte Carlo simulation involved scenarios with three cluster sizes. Our results were checked for
other realistic cluster size distributions, involving five and six cluster sizes. Similar to what was found in
earlier studies [21,22], the results for these scenarios were in line with the results obtained for the three-
cluster-size scenarios of the present simulation study.
Finally, randomized trials may involve a binary outcome, such as smoking cessation [27] or offering a
follow-up appointment [37], which could be analysed through the logistic mixed effects model. A useful
extension of the present study would be the derivation of the ARE and its Taylor approximation for this
model, as well as their evaluation in a Monte Carlo simulation study. For cluster randomized trials with
homogeneous clustering, this has proven to be a feasible approach [38].
Appendix A: Asymptotic RE for the ML estimator of the treatment effect
Starting from the linear mixed model in Eqn (1), one can derive, along lines similar to Candel et al.
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. The asymptotic variance-covariance matrix is obtained by taking the
























, with m t and mc the average cluster sizes in the treatment and
control condition, respectively. The ARE of unequal versus equal cluster sizes, keeping the average





























Appendix B: Optimal restoration of the efficiency loss due to varying cluster sizes
Let RE denote the relative efficiency of varying versus equal cluster sizes. Assume equal cluster sizes
within (but not between) treatment arms, and assume that Kt and Kc are the cluster numbers in the treat-
ment and control arm that minimize the variance of the treatment effect estimator under the following
cost function:
C ¼ C0 þ Kt ct þ Kc cc ; (B1)




c are the total costs of a treatment and control cluster. To restore
the efficiency loss due to varying cluster sizes, we can increase the number of clusters in both arms, that
is, take as sample size ftKt and fcKc,, where ft and fc are the multiplication factors in the treatment and
control arm respectively, needed to restore the efficiency loss. From Eqn (A3), these factors should satisfy
















This constraint can be rewritten as
f t ¼
α
RE αþ βð Þ  β=f c
: (B3)
The two factors ft and fc, are now chosen such that the cost function in Eqn (B1) is minimized:
C0 þ f tKtct þ f cKccc ¼ C0 þ Ktct α= RE αþ βð Þ  β=f cð Þ þ f cKccc : (B4)




RE αþ βð Þ  β=f cð Þ2
 1
f 2c
þ Kccc ¼ 0 ⇔
B5Copyright © 2016 John Wiley & Sons, Ltd. Statist. Med. 2016, 35 2000–2015












The ratio of optimal cluster numbers in case of constant cluster sizes satisfies (Eqn (6) in [13])














, where γ is the
ARE for the mean outcome in the control arm divided by the ARE for the mean outcome in the treatment

















Substituting this result into Eqn (B5), we obtain, after some rewriting:



















Solving for fc yields two solutions, only one of which is in the domain for fc as defined by Eqn (B3),
that is, [β/RE× (α+ β), ∞), namely
f optc ¼
αþ β ffiffiγp




RE αþ βð Þ : (B8)
Because the second derivative of Eqn (B4) is positive for fc in Eqn (B8), it minimizes the costs.
For constant cluster sizes, we have γ=1 and RE=1, and so f optt = f
opt
c =1. For varying cluster sizes with
the same cluster size distribution and variance parameters in both treatment arms, γ=1 and so f optt =f
opt
c =1/RE.






, where γ is the relative efficiency for the mean outcome in the control arm divided by
the relative efficiency for the mean outcome in the treatment arm [19]. So if γ>1, the efficiency loss due to
cluster size variation in the treatment arm is larger than in the control arm and more clusters should be added
to the treatment arm than to the control arm in repairing the efficiency loss. A problem with the cost-
minimizing factors in Eqn (B8) is that they require knowledge on α, β and γ, which mostly will not
be available. However, choosing ft= fc= 1/RE can be shown to be highly efficient, with costs differing
from the costs for the optimal replication factors by less than 1% in almost all cases. A proof of this
result is available upon request from the first author.
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